共 80 条
[21]
Goldstein FW(1997)Phamacokinetics and pharmacodynamics of oral grepafloxacin in patients with acute bacterial exacerbations of chronic bronchitis J Antimicrob Chemother 40 45-57
[22]
Zhanel GG(2000)Pharmacodynamics and pharmacokinetics of levofloxacin Chemother 46 6-14
[23]
Hoban DJ(1999)Fluoroquinolones in Canada: A critical review Can J Infect Dis 10 207-238
[24]
Harding GKM(2000)Comparative activities of ciprofloxacin and levofloxacin against Streptococcus pneumoniae in an in vitro dynamic model Antimicrob Agents Chemother 44 773-774
[25]
Jacobs MR(2000)Comparison of fluoroquinolones based on pharmacokinetic/pharmacodynamic parameters Pharmacother 20 417-428
[26]
Jacobs MR(1999)Antibiotic use in community practice: Assessing quantity, indications and appropriateness and its relationship to the development of antibiotic resistance Drugs 57 871-881
[27]
Bajaksouzian S(1999)Prevalence of antibiotic resistance in respiratory tract isolates of Streptococcus pneumoniae: results of a Canadian national surveillance study Antimicrob Agents Chemother 43 2504-2509
[28]
Zilles A(1998)Prevalence of antibiotic resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 Results from the SENTRY Antibiotic Surveillance Program Clin Infect Dis 27 764-770
[29]
Andes D(1996)A multicentre collaborative study of the antimicrobial susceptibility of communityacquired, lower respiratory tract pathogens 1992–1993: the Alexander Project J Antimicrob Chemother 38 1-57
[30]
Craig WA(1999)Acute otitis media: management and surveillance in the area of pneumococcal resistance, a report from the Drug Resistant Streptococcus pneumoniae Therapeutic Working Group Pediatr Infect Dis J 18 1-9